宇瞳光學(300790.SZ):車載領域已與國際頭部tiler1接洽,力爭2年內實現車載光學產品向海外頭部公司批量供貨
格隆匯9月26日丨宇瞳光學(300790.SZ)於近期接受投資者調研,就“公司境外營收佔比較低,海外市場拓展有何規劃,目前有哪些大客户在合作或接洽之中?”,公司表示,公司上半年境外營收佔比為11.65%,較上年同期10.37%提升1.28個百分點,公司十分重視海外市場的開拓,多年來境外營收金額及佔比逐漸提高,由於海外客户導入週期長,進度相對緩慢,後續將從增加海外客户份額和開拓新客户入手,努力提高境外業務佔比。安防領域,公司爭取與亞瑪遜、安訊士等頭部公司加大項目合作規模;車載領域,已與國際頭部tiler1接洽,力爭2年內實現車載光學產品向海外頭部公司批量供貨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.